Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials

Published:2017-06 Issue: Volume:188 Page:18-25
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Selker Harry P.,Udelson James E.,Ruthazer Robin,D'Agostino Ralph B.,Nichols Melissa,Ben-Yehuda Ori,Eitel Ingo,Granger Christopher B.,Jenkins Paul,Maehara Akiko,Patel Manesh R.,Ohman E. Magnus,Thiele Holger,Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. The wavefront phenomenon of ischemic cell death. Myocardial infarct size vs duration of coronary occlusion in dogs;Reimer;Circulation,1977

2. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?;Braunwald;Circulation,1989

3. Infarct size reduction in acute myocardial infarction;McAlindon;Heart,2015

4. Utility of cardiac biomarkers in predicting infarct Size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction;Chia;J Am Coll Cardiol Intv,2008

5. Infarct size measured by single-photon emission computed tomographic imaging with 99m-Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction;Gibbons;Circulation,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypothermia for Cardioprotection in Acute Coronary Syndrome Patients: From Bench to Bedside;Journal of Clinical Medicine;2024-09-12

2. Impact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock;JACC: Heart Failure;2024-09

3. Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation;Circulation;2024-04-23

4. An Opportune Time to Consider Glucose–Insulin–Potassium Therapy for Takotsubo Syndrome;American Journal of Cardiovascular Drugs;2023-08-01

5. Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review;Molecular and Cellular Biochemistry;2023-03-09